The value of fasting in the diagnosis of medium-chain acyl-CoA dehydrogenase deficiency

The value of fasting in the diagnosis of medium-chain acyl-CoA dehydrogenase deficiency

ABSTRACT Female patient carrier of medium-chain acyl-CoA dehydrogenase deficiency (MCADD) with recurrent clinical episodes of hypoglycemia and altered level of consciousness, presented changes in blood acylcarnitine profile by tandem mass spectrometry and in the urinary organic acid analysis by gas...

Full description

Bibliographic Details
Main Authors:	Carmen R Vargas, Marion Deon, Angela Sitta, Daniella M Coelho, Patricia D Silva, Larissa Murussi, Laura V Fleith, Carolina Crespo, Moacir Wajner, Maria Teresa V Sanseverino
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Patologia Clínica 2020-05-01
Series:	Jornal Brasileiro de Patologia e Medicina Laboratorial
Subjects:	mitochondrial β-oxidation defects MCADD fasting acylcarnitines organic acids
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442020000100702&tlng=pt

Similar Items

Medium Chain Acyl CoA Dehydrogenase Deficiency and Eating Disorders: An Underreported Coincidence
by: Kharis A. Burns, et al.
Published: (2024-04-01)

Successful perioperative management of a pediatric patient with medium-chain acyl-CoA dehydrogenase deficiency using a continuous tissue glucose monitoring device: A case report
by: Ito Hidekazu, et al.
Published: (2021-01-01)

Metabolic Outcomes of Anaplerotic Dodecanedioic Acid Supplementation in Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficient Fibroblasts
by: Igor Radzikh, et al.
Published: (2021-08-01)

Biochemical and molecular characteristics among infants with abnormal newborn screen for very-long-chain acyl-CoA dehydrogenase deficiency: A single center experience
by: Jariya Upadia, et al.
Published: (2023-12-01)

Management of pregnancy in a patient with long‐chain 3‐hydroxyacyl CoA dehydrogenase deficiency
by: Loai A. Shakerdi, et al.
Published: (2022-07-01)

Personalised modelling of clinical heterogeneity between medium-chain acyl-CoA dehydrogenase patients
by: Christoff Odendaal, et al.
Published: (2023-09-01)

Corresponding increase in long-chain acyl-CoA and acylcarnitine after exercise in muscle from VLCAD mice
by: Frank ter Veld, et al.
Published: (2009-08-01)

Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?
by: Mu X, et al.
Published: (2022-01-01)

Medium‐chain Acyl‐COA dehydrogenase deficiency: Pathogenesis, diagnosis, and treatment
by: Emily Mason, et al.
Published: (2023-01-01)

New Acylcarnitine Ratio as a Reliable Indicator of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency
by: Galina V. Baydakova, et al.
Published: (2023-08-01)

Palmitoylcarnitine impairs immunity in decompensated cirrhosis
by: Ingrid Wei Zhang, et al.
Published: (2024-11-01)

Medium-Chain Acyl-CoA Dehydrogenase Deficiency in an Infant with Dilated Cardiomyopathy
by: Marcello Marc&#236;, et al.
Published: (2009-01-01)

Medium-Chain Acyl-CoA Dehydrogenase Deficiency in Gene-Targeted Mice.
Published: (2005-08-01)

Medium chain acyl-CoA dehydrogenase deficiency in a premature infant
by: Steven F. Dobrowolski, et al.
Published: (2017-11-01)

Medium-chain acyl-CoA dehydrogenase deficiency in gene-targeted mice.
by: Ravi J Tolwani, et al.
Published: (2005-08-01)

Acyl-CoA Dehydrogenase Deficiency and RS
by: J Gordon Millichap
Published: (1994-05-01)

MCAD-Deficiency with Severe Neonatal Onset, Fatal Outcome and Normal Acylcarnitine Profile
by: Ralph Fingerhut, et al.
Published: (2017-08-01)

Structural basis for expanded substrate specificities of human long chain acyl-CoA dehydrogenase and related acyl-CoA dehydrogenases
by: Beena Narayanan, et al.
Published: (2024-06-01)

Neonatal Screening for Medium-Chain Acyl-CoA Dehydrogenase Deficiency—Alternative Approaches
by: Rodney J. Pollitt
Published: (2016-03-01)

Molecular characterization of L-CPT I deficiency in six patients: insights into function of the native enzyme
by: Nicholas F. Brown, et al.
Published: (2001-07-01)

Comprehensive metabolomic/lipidomic characterization of patients with mitochondrial ATP synthase, short-chain acyl-CoA dehydrogenase and combined variant deficiencies
by: Dana Dobešová, et al.
Published: (2025-02-01)

Acyl-CoA thioesterase-2 facilitates mitochondrial fatty acid oxidation in the liver[S]
by: Cynthia Moffat, et al.
Published: (2014-12-01)

Parental Experiences of Raising a Child With Medium Chain Acyl-CoA Dehydrogenase Deficiency
by: Hilary Piercy, et al.
Published: (2017-05-01)

Study of very long chain acyl-CoA dehydrogenase (VLCAD) with cardiomyopathy using a deuterated substrate
by: Osorio, José Henry
Published: (2014-10-01)

Lipidomic analysis identifies long-chain acylcarnitine as a target for ischemic stroke
by: Xin-Xin Huang, et al.
Published: (2024-07-01)

Medium & long-chain acylcarnitine’s relation to lipid metabolism as potential predictors for diabetic cardiomyopathy: a metabolomic study
by: Dan-meng Zheng, et al.
Published: (2021-11-01)

Altered Acylcarnitine Metabolism Is Associated With an Increased Risk of Atrial Fibrillation
by: Einar Smith, et al.
Published: (2020-11-01)

Clinical, Biochemical, and Molecular Analyses of Medium-Chain Acyl-CoA Dehydrogenase Deficiency in Chinese Patients
by: Zhuwen Gong, et al.
Published: (2021-03-01)

Functional effects of different medium-chain acyl-CoA dehydrogenase genotypes and identification of asymptomatic variants.
by: Marga Sturm, et al.
Published: (2012-01-01)

Newborn Screening for Mitochondrial Carnitine-Acylcarnitine Cycle Disorders in Zhejiang Province, China
by: Duo Zhou, et al.
Published: (2022-03-01)

Recent Advances in the Pathophysiology of Fatty Acid Oxidation Defects: Secondary Alterations of Bioenergetics and Mitochondrial Calcium Homeostasis Caused by the Accumulating Fatty Acids
by: Alexandre Umpierrez Amaral, et al.
Published: (2020-11-01)

Assessment of reference intervals of acylcarnitines in newborns in Siberia
by: N. V. Nemchinova, et al.
Published: (2022-12-01)

Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France
by: Hamers Françoise F, et al.
Published: (2012-06-01)

Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency.
by: KY Tserng, et al.
Published: (1990-05-01)

Medium-chain acyl-CoA dehydrogenase deficiency: Two novel mutations identified in a retrospective screening
by: Andraz Smon, et al.
Published: (2018-04-01)

Essential oils can cause false-positive results of medium-chain acyl-CoA dehydrogenase deficiency
by: Yasuko Mikami-Saito, et al.
Published: (2020-12-01)

Plasma acylcarnitine and diabetic retinopathy: A study from Eastern China
by: Dongzhen Jin, et al.
Published: (2022-10-01)

MRI and Infantile-Onset Leukoencephalopathy
by: J Gordon Millichap
Published: (2012-07-01)

Serum Metabolomic Signatures for Knee Cartilage Volume Loss over 10 Years in Community-Dwelling Older Adults
by: Zikun Xie, et al.
Published: (2022-06-01)

Amino Acid and Acylcarnitine Levels in Chronic Patients with Schizophrenia: A Preliminary Study
by: Irina A. Mednova, et al.
Published: (2021-01-01)